OTULFI I.V.
Analogs of OTULFI I.V.
Find cheaper analogs and generic equivalents for OTULFI I.V..
Active Ingredient: USTEKINUMAB
Product Overview
About OTULFI I.V.
OTULFI I.V. is a prescription medication containing the active ingredient USTEKINUMAB, a human monoclonal antibody that selectively targets and binds to the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23). It is administered intravenously and is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and certain cases of Crohn's disease.
Key Benefits & Uses
- Treatment of moderate to severe plaque psoriasis, including nail and scalp psoriasis
- Treatment of psoriatic arthritis, including symptoms such as joint pain and swelling
- Treatment of moderate to severe Crohn's disease, including symptoms such as abdominal pain and diarrhea
Active Ingredient & Action
USTEKINUMAB works by inhibiting the activity of IL-12 and IL-23, which are pro-inflammatory cytokines involved in the pathogenesis of psoriasis and Crohn's disease. By binding to the p40 subunit of these cytokines, USTEKINUMAB reduces the production of pro-inflammatory molecules and helps to alleviate symptoms associated with these conditions.
Important Notes
OTULFI I.V. is available by prescription only and should be used under the guidance of a healthcare professional. Patients should be monitored for signs of infection, including fever, chills, and fatigue, as USTEKINUMAB may increase the risk of infections. Additionally, patients should be advised to report any changes in their symptoms or medication regimen to their healthcare provider.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.